circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma.

Authors:
Lin XH; Liu ZY; Zhang DY; Zhang S; Tang WQ and 6 more

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00342-6

PMCID:
PMC9644583

PMID:
36348379

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabil…
Zhou W; Li S; Wang H and 8 more (2024) - Transparency Score: 4/6
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive …
Shen XT; Xie SZ; Zheng X and 17 more (2024) - Transparency Score: 4/6
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting c…
Zhao Q; Zong H; Zhu P and 4 more (2024) - Transparency Score: 3/6
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, …
Liu J; Jiang P; Lu Z and 2 more (2024) - Transparency Score: 3/6
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateEthical approval was obtained from the Research Ethics Committee of Zhongshan Hospital of Fudan University (Shanghai, China), and each patient was asked for written informed consent. Consent for publicationNot applicable Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (Grant No.8197100979) and Natural Science Foundation of the Autonomous Region (Grant No. XZ 2019 ZR G-117)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025